Prescription drug · ANDA
Betamethasone Dipropionate USP, 0.05% NDC 52817-824
Betamethasone dipropionate .5 mg/g · Ointment · Topical · TruPharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52817-824-15 | 52817082415 | 1 TUBE in 1 CARTON (52817-824-15) / 15 g in 1 TUBEMarketed from Feb 18, 2022 | |
| 52817-824-45 | 52817082445 | 1 TUBE in 1 CARTON (52817-824-45) / 45 g in 1 TUBEMarketed from Feb 18, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Betamethasone Dipropionate USP, 0.05%
- Generic name (nonproprietary)
- betamethasone dipropionate usp, 0.05%
- Active ingredients
- Betamethasone dipropionate — .5 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Labeler
- TruPharma LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215186
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 52817-824_48aaf6af-2b7b-7451-e063-6294a90a66aaSPL ID 48aaf6af-2b7b-7451-e063-6294a90a66aaSPL set ID fc34987a-e803-4ac8-8a1e-9bdadd3f8b56RxCUI 197405UNII 826Y60901UUPC 0352817824455
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452817082415followed by a unit qualifier and the quantityPackage 52817-0824-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.